Quanterix Corporation (QTRX)

Market Cap	221.41M
Revenue (ttm)	137.42M
Net Income (ttm)	-38.53M
Shares Out	38.78M
EPS (ttm)	-1.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	268,789
Open	5.50
Previous Close	5.28
Day's Range	5.43 - 5.83
52-Week Range	4.67 - 19.18
Beta	1.11
Analysts	Buy
Price Target	16.20 (+183.71%)
Earnings Date	May 12, 2025

About QTRX

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Dec 7, 2017
• Employees: 471
• Stock Exchange: NASDAQ
• Ticker Symbol: QTRX
• Website: https://www.quanterix.com

Financial Performance

In 2024, Quanterix's revenue was $137.42 million, an increase of 12.30% compared to the previous year's $122.37 million. Losses were -$38.53 million, 35.9% more than in 2023.

Analyst Forecast

According to 5 analysts, the average rating for QTRX stock is "Buy." The 12-month stock price forecast is $16.2, which is an increase of 183.71% from the latest price.

Price Target

$16.2

(183.71% upside)

Analyst Consensus: Buy